Results 151 to 160 of about 1,333,557 (170)
Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107. [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Plasmatherapy in Atypical Hemolytic Uremic Syndrome
Seminars in Thrombosis and Hemostasis, 2010Anne-Laure Sellier-Leclerc +2 more
exaly
Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry
Kidney International Reports, 2019Daniel Landau +2 more
exaly
Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1)
Renal Failure, 2010Kevin J Marchbank +2 more
exaly
Pathogenesis of Atypical Hemolytic Uremic Syndrome
Journal of Atherosclerosis and Thrombosis, 2019Masaomi Nangaku, Yoichirô Ikeda
exaly
Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome
Blood, 2013Jordan D Dimitrov +2 more
exaly
Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment
Therapeutic Apheresis and Dialysis, 2019Vinod Krishnappa +2 more
exaly

